-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Proton pump inhibitors (PPI) are used to treat many diseases that require suppression of gastric acid secretion, and PPI is one of the most commonly prescribed drugs in the world.
Proton pump inhibitors (PPI) are used to treat many diseases that require suppression of gastric acid secretion, and PPI is one of the most commonly prescribed drugs in the world.
This study is a cohort study.
After calculating the propensity score weights, a total of 39799 PPI and 38967H2RA patients were included in the study.
This study confirmed that even in high-risk areas of gastric cancer, long-term use of PPI and H2RA treatment did not show a higher risk of gastric cancer.
This study confirmed that even in high-risk areas of gastric cancer, long-term use of PPI and H2RA treatment did not show a higher risk of gastric cancer.
Original source:
Shin, Ga-Yeong.
Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
Leave a message here